New Key Statistics Module, Z-Score and F-Score
NAS:CTSO Key Ratios
| Market Cap $ M | 20.20 |
| Enterprise Value $ M | 45.21 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 0.54 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 37.00 |
| EPS (TTM) $ | -5.80 |
| Beneish M-Score | -3.41 |
| 10-y EBITDA Growth Rate % | 5.90 |
| 5-y EBITDA Growth Rate % | 19.20 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.92 |
| EV-to-EBITDA | -3.24 |
| PEG | -- |
| Shares Outstanding M | 3.15 |
| Net Margin (%) | -48.94 |
| Operating Margin % | -32.65 |
| Pre-tax Margin (%) | -50.02 |
| Quick Ratio | 0.50 |
| Current Ratio | 0.66 |
| ROA % (ttm) | -42.07 |
| ROE % (ttm) | -325.79 |
| ROIC % (ttm) | -37.08 |
| Dividend Yield % | -- |
| Altman Z-Score | -12.18 |
CTSO Number of Guru Trades
CTSO Volume of Guru Trades
Gurus Latest Trades with NAS:CTSO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CTSO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
CytoSorbents Corp Insider Transactions
No Available Data
News about NAS:CTSO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers